Randomized controlled trial on the safety and EffectiVeness Of toLvaptan for flUid retenTion after OpeN heart surgery

Randomized controlled trial on the safety and EffectiVeness Of toLvaptan for flUid retenTion after OpeN heart surgery - REVOLUTION study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011721

Enrollment

Registered

2013-09-12

Start date

2013-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

opoen heart surgery

Interventions

tolvaptan standard therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: heart failure open heart surgery

Exclusion criteria

Exclusion criteria: hypersensitivity anuresis hypernatremia pregnant woman malignant tumor serious liver samage and renal failure

Design outcomes

Primary

Measure	Time frame
The days before returning to preoperative weight after surgery	—

Countries

Japan

Contacts

Public ContactTomoaki Kudo

Yamaguchi university Surgery and clinical science

t-kudoh@yamaguchi-u.ac.jp+81-836-22-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026